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Background
Autoinflammatory diseases are rare disorders that lead to
significant morbidity and mortality. Due to the low patient
numbers, evidence-based guidelines are lacking and man-
agement is mostly based on physician’s experience. In
2012, a European initiative called SHARE was launched to
optimize and disseminate diagnostic and management
regimens in Europe for children and young adults with
rheumatic diseases. One of the aims of SHARE was to pro-
vide evidence-based recommendations for the manage-
ment of the autoinflammatory diseases Cryopyrin-
Associated Periodic Syndromes (CAPS), Tumor necrosis
factor Receptor Associated Periodic Syndrome (TRAPS)
and Mevalonate Kinase Deficiency (MKD).
Methods
Evidence-based recommendations were developed using
the European League Against Rheumatism (EULAR)
standard operating procedure. An expert committee of
paediatric and adult rheumatologists was convened.
Recommendations derived from the systematic literature
review were evaluated by an online survey and subse-
quently discussed at a consensus meeting using Nominal
Group Technique. Recommendations were accepted if
more than 80% agreement was reached.
Results
In total, four overarching principles, six recommendations
on diagnosis, twenty recommendations on therapy and
twelve recommendations on monitoring were accepted
with ≥80% agreement among the experts. Topics include
(but are not limited to) the use of validated scores for
diagnosis and disease activity, therapy with biologicals,
NSAIDs and corticosteroids, and items to assess in moni-
toring of a patient.
Conclusion
The SHARE initiative provides recommendations for the
management of the autoinflammatory diseases CAPS,
TRAPS and MKD.
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